Ref (type)	Population	Outcome, Interventions	Results and statistical analysis	Effect size	Favours
Treatment failure rates
Systematic review	497 people	Treatment failure rates 2 weeks (short term) 73/176 (41%) with clotrimazole 103/321 (32%) with econazole	RR 1.13 95% CI 0.92 to 1.39		Not significant
Systematic review	41 people	Treatment failure rates 2 weeks (short term) 6/20 (30%) with miconazole 1/21 (5%) with sulconazole	RR 6.30 95% CI 0.83 to 47.80 The wide CI suggests that the RCT was likely to have been underpowered to detect a clinically important difference between groups		Not significant
Systematic review	105 people	Treatment failure rates 6 weeks 0/17 (0%) with bifonazole 0/19 (0%) with croconazole	RR not estimable
Systematic review	264 people	Treatment failure rates 6 weeks 23/131 (18%) with bifonazole 111/133 (83%) with flutrimazole	RR 0.21 95% CI 0.14 to 0.31	Moderate effect size	bifonazole
Systematic review	28 people	Treatment failure rates 6 weeks 4/14 (29%) with bifonazole 5/14 (36%) with miconazole	RR 0.80 95% CI 0.27 to 2.37		Not significant
Systematic review	497 people	Treatment failure rates 6 weeks 64/176 (36%) with clotrimazole 85/321 (26%) with econazole	RR 0.95 95% CI 0.31 to 2.88		Not significant
Systematic review	100 people	Treatment failure rates 6 weeks 19/50 (38%) with clotrimazole 18/50 (36%) with ketoconazole	RR 1.06 95% CI 0.63 to 1.76		Not significant
Systematic review	220 people	Treatment failure rates 6 weeks 21/57 (37%) with miconazole 18/63 (29%) with tioconazole	RR 1.29 95% CI 0.77 to 2.16		Not significant